Aerosolized active agent delivery

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20050090798A1
SERIAL NO

10627591

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to methods and devices for delivering an active agent formulation to the lung of a human patient. The active agent formulation may be in dry powder form, it may be nebulized, or it may be in admixture with a propellant. The active agent formulation is delivered to a patient at an inspiratory flow rate of less than 17 liters per minute. The bioavailability of the active agent was found to increase at these flow rates when compared to inspiratory flow rates of 17 liters per minute or more.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS PHARMA AG4002 BASEL

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Clark, Andrew Half Moon Bay, CA 152 2387
Foulds, George H Chester, CT 4 258

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation